These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 10194083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
    Cartledge JD, Denning DW, Dupont B, Clumeck N, De Wit S, Midgley J, Hawkins DA, Gazzard BG.
    AIDS; 1998 Mar 05; 12(4):411-6. PubMed ID: 9520171
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Candidiasis at ICAAC.
    Barr D, Smart T.
    GMHC Treat Issues; 1995 Oct 05; 9(10):13. PubMed ID: 11362914
    [Abstract] [Full Text] [Related]

  • 11. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
    Weig M, Müller FM.
    Antimicrob Agents Chemother; 2001 Mar 05; 45(3):966-8. PubMed ID: 11181393
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
    Horn CA, Washburn RG, Givner LB, Peacock JE, Pegram PS.
    AIDS; 1995 May 05; 9(5):533-4. PubMed ID: 7639986
    [No Abstract] [Full Text] [Related]

  • 18. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
    Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG, AIDS Clinical Trials Group Study Team 323, Mycoses Study Group Study Team 40.
    Clin Infect Dis; 2005 Nov 15; 41(10):1473-80. PubMed ID: 16231260
    [Abstract] [Full Text] [Related]

  • 19. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F, Arzeni D, Del Prete MS, Sinicco A, Falconi Di Francesco L, Pasticci MB, Lamura L, Nuzzo MM, Burzacchini F, Coppola S, Chiodo F, Scalise G.
    J Antimicrob Chemother; 1998 May 15; 41(5):541-8. PubMed ID: 9630407
    [Abstract] [Full Text] [Related]

  • 20. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD, Chunchanur SK, Halesh LH, Yasmeen K, Chandrasekhar MR, Patil BS.
    Southeast Asian J Trop Med Public Health; 2008 May 15; 39(3):492-5. PubMed ID: 18564689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.